Triple Negative Metastatic Breast Cancer clinical trials

Explore recruiting triple negative metastatic breast cancer clinical trials.

Recruiting triple negative metastatic breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Triple Negative Metastatic Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ISIdE: Open label, multicentric, single-arm phase IIIB trial to evaluate the safety and efficacy of sacituzumab govitecan in triple negative metastatic breast cancer patients with a biomarker analysis.

France, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Triple Negative Metastatic Breast Cancer trials by city

Triple Negative Metastatic Breast Cancer in Toronto Triple Negative Metastatic Breast Cancer in Vancouver Triple Negative Metastatic Breast Cancer in Montreal Triple Negative Metastatic Breast Cancer in Calgary Triple Negative Metastatic Breast Cancer in Edmonton Triple Negative Metastatic Breast Cancer in Ottawa Triple Negative Metastatic Breast Cancer in Winnipeg Triple Negative Metastatic Breast Cancer in Quebec City Triple Negative Metastatic Breast Cancer in Hamilton Triple Negative Metastatic Breast Cancer in Kitchener Triple Negative Metastatic Breast Cancer in London Triple Negative Metastatic Breast Cancer in Halifax Triple Negative Metastatic Breast Cancer in New York Triple Negative Metastatic Breast Cancer in Los Angeles Triple Negative Metastatic Breast Cancer in Chicago Triple Negative Metastatic Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease